Right ventricular thrombus following a left anterior descending infarction: a rare case report of a common culprit Authors: Tamar Bigvava, Andres Hoechli, Pablo Anabitarte, Robert Manka, Verena C Wilzeck, Edgar Francisco Carrizales Sepulveda, Avinash Radhakrishna, Deepti Ranganathan Published: 2026 ABSTRACT AbstractBackgroundRight ventricular (RV) thrombus is a rare complication of myocardial infarction, most often associated with inferior infarcts or pulmonary embolism. This case highlights a unique presentation of RV thrombus following an anterior ST-elevation myocardial infarction (STEMI), expanding our understanding of infarct extension patterns in left coronary dominance and underscoring the diagnostic value of advanced cardiac imaging.Case summaryA 39-year-old man presented with chest pain and dyspnoea. Electrocardiography and cardiac biomarkers confirmed an anterior STEMI. Coronary angiography revealed a thrombotic occlusion of the mid-left anterior descending artery (LAD) in a left-dominant system, treated with stenting. Four days later, transthoracic echocardiography detected an RV thrombus, which was confirmed on cardiac magnetic resonance imaging (MRI). Imaging revealed extensive myocardial infarction in the LAD territory, including the apex of both ventricles with transmural necrosis and significant microvascular obstruction. The patient was anticoagulated and subsequently received a two-chamber implantable cardioverter-defibrillator due to episodes of ventricular fibrillation. Follow-up imaging showed thrombus resolution.ConclusionThis case demonstrates that anterior infarctions due to wraparound LAD occlusion can extend into the right ventricle and result in thrombus formation, even with preserved RV function. It reinforces the importance of cardiac MRI for comprehensive assessment and highlights the need for awareness of atypical infarct complications.Keywords: Right ventricular thrombus, Anterior myocardial infarction, Left anterior descending artery, Cardiac magnetic resonance imaging, Left coronary dominance, Microvascular obstruction, Case report Anterior STEMI due to wrap-around LAD occlusion may involve both ventricular apices and lead to RV thrombus, even with preserved RV function. Anterior STEMI due to wrap-around LAD occlusion may involve both ventricular apices and lead to RV thrombus, even with preserved RV function. Cardiac magnetic resonance allows accurate infarct sizing and improved prediction of complications such as thrombus and microvascular obstruction. Cardiac magnetic resonance allows accurate infarct sizing and improved prediction of complications such as thrombus and microvascular obstruction. Introduction Right ventricular (RV) thrombus is a rare but potentially life-threatening condition, most commonly associated with massive pulmonary embolism (PE) or RV infarction secondary to inferior ST-elevation myocardial infarction (STEMI).1,2 In contrast, thrombus formation within the RV following anterior myocardial infarction is extremely rare. However, this can be anatomically explained by coronary perfusion patterns: while the right coronary artery (RCA) typically supplies the majority of the RV free wall, the left anterior descending (LAD) artery may supply the anterior septum and RV apex, particularly in the presence of a wraparound LAD or left coronary dominance.3,4 Cardiovascular magnetic resonance (CMR) studies have shown that during anterior STEMI, a substantial portion of the RV apex and adjacent septum may be at risk for ischaemia.5 However, infarction in these regions remains uncommon, likely due to the effective myocardial salvage through alternative coronary supply, such as the RCA or collateral vessels.5 Documented cases of RV thrombus in this context are rare, with only two published case reports identified to date.6,7 We present a unique case of RV thrombus developing after extensive anterior STEMI due to mid-LAD occlusion, with infarct extension into the RV apex confirmed on CMR. Summary figure Case presentation A 39-year-old man presented to the emergency department with acute chest pain and shortness of breath. The pain began 4 days ago as a lumbar backache, later progressing to chest discomfort radiating to the right arm and neck. On the day of admission, he developed resting dyspnoea, prompting emergency evaluation. His medical history includes arterial hypertension and a positive family history of premature coronary artery disease. On arrival, the patient was alert and oriented. Vital signs showed tachycardia (heart rate 120 beats per minute) and borderline hypoxaemia (SpO2 92% on room air). Physical examination was unremarkable. Electrocardiography (ECG) showed sinus tachycardia with ST-segment elevations in leads V1-V6, I, II, aVF, and aVL. Q waves were present in the anterior leads, along with an intraventricular conduction delay in V5 (Figure 1). Laboratory results showed markedly elevated cardiac biomarkers with a high-sensitivity troponin 3916 ng/L (normal < 14 ng/L) and creatine kinase 2701 U/L (normal < 190 U/L), consistent with an anterior STEMI. Electrocardiogram (ECG) demonstrating sinus tachycardia with widespread ST-segment elevations in leads V1–V6, I, II, aVF, and aVL. Pathological Q waves are present in the anterior leads. Intraventricular conduction delay is noted in lead V5. Coronary angiography demonstrated a subacute anteroseptal STEMI due to thrombotic occlusion of the mid LAD artery (Figure 2A). The LAD was large with a wraparound course and gave rise to a posterior branch supplying the inferior wall, functionally serving as a posterior descending artery (PDA)—thereby explaining the inferior ST segment elevations on ECG. The culprit lesion was successfully treated with thromboaspiration followed by a drug-eluting stent implantation (Orsiro Mission 3 × 26 mm). The dominant left circumflex artery (LCX) and rudimentary RCA were free of stenosis. Transthoracic echocardiography (TTE) revealed moderately reduced left ventricular ejection fraction (LVEF 35%) with dyskinesia of the apex and apical segments and akinesia of the anterior and septal midventricular segments. Systolic function of the RV was preserved. The patient was started on dual antiplatelet therapy with aspirin and ticagrelor, high-intensity statin therapy, fondaparinux, and guideline-directed medical therapy for heart failure, including sacubitril/valsartan, bisoprolol, spironolactone, dapagliflozin, and torasemide. (A) Coronary angiography in RAO 30°, caudal 20° projection showing occlusion of the mid LAD. (B) CMR T2-weighted short-axis image at apical level demonstrating extensive myocardial oedema (indicated by arrows). (C) CMR late gadolinium Enhancement image in the four-chamber view and (D). short-axis view showing septo-apical thrombus in RV (blue arrow) and transmural infarction with extensive microvascular obstruction in the LAD territory (red arrows). Notably, 4 days after admission, repeat TTE performed to assess for post-infarction complications demonstrated a small, wall-adherent thrombus in the septoapical RV. RV size and systolic function were preserved (TAPSE 24 mm, TDI RV S´ velocity 0.10 m/s, RV end-diastolic area 21.65 cm2, fractional area change [FAC] 42%). LV was unchanged, with regional wall motion abnormalities in the LAD territory. Diastolic dysfunction with elevated left atrial pressure was noted. The RV thrombus was subsequently confirmed by cardiac magnetic resonance imaging (CMR) (see Supplementary material online, Video S1). CMR further revealed extensive myocardial oedema involving the entire septum, midventricular anterior wall, and apical segments, including the apex of both ventricles, as demonstrated by T2-weighted imaging (Figure 2B) and parametric mapping. T1 and T2 mapping values were globally elevated, exceeding the regions of T2 signal hyperintensity, indicating widespread acute inflammatory changes. Early and late gadolinium enhancement depicted the thrombus as a hypointense structure within the RV apex and revealed extensive transmural infarction of the basal anteroseptal, mid-ventricular anterior and anteroseptal, the apical anterior, septal, and inferior segments as well as the apex of both ventricles (Figure 2 C and D), corresponding to regional akinesia. The infarct core demonstrated pronounced signal hypointensity consistent with marked microvascular obstruction (MVO) and intramyocardial haemorrhage. Global RV function remained preserved, and no evidence of ventricular septal defect (VSD) was found. The patient was started on anticoagulation with a non–vitamin K antagonist oral anticoagulant (apixaban 5 mg twice daily). Aspirin and fondaparinux were discontinued, and ticagrelor was replaced with clopidogrel. On follow-up echocardiography, there was no evidence of residual RV thrombus, and the LVEF had improved to 40%. Based on these findings, anticoagulation was discontinued, and dual antiplatelet therapy with aspirin and ticagrelor was reinitiated. Due to multiple episodes of ventricular fibrillation requiring in-hospital resuscitation, a dual-chamber implantable cardioverter-defibrillator was implanted in accordance with current guidelines8 and amiodarone was added to the treatment regimen. The timeline of clinical events and interventions is shown in Figure 3. Timeline of clinical events and interventions. Discussion RV thrombus is an uncommon complication of anterior STEMI. In this case, a mid-LAD occlusion in the setting of left coronary dominance led to infarct extension into the septo-apical RV, where a thrombus subsequently formed despite preserved RV function. The patient’s history of lumbar back pain for several days before admission suggests a subacute presentation, which may have contributed to the extensive transmural infarction and MVO observed on cardiac MRI, creating the substrate for thrombus development. Prior studies have shown that inferior ST-segment changes during anterior MI are more common when a wrapped LAD supplies a larger territory, including inferoapical regions. This provides a mechanistic link between LAD anatomy and extensive infarction patterns.9 While RV myocardium can be at risk during anterior MI, documented cases of thrombus in this context are exceedingly rare, with only two similar reports to date.6,7 Kim et al.7 described a patient with simultaneous LV and RV apical thrombi following distal occlusion of a wrapped LAD, detected by MRI. As in our case, thrombus formation was attributed to infarct extension into both ventricles and endothelial injury, creating a prothrombotic environment. Boukantar et al.6 reported isolated RV apical thrombus and PE in a patient with proximal LAD occlusion and delayed presentation. In our case, alternative diagnoses, including PE and intracardiac mass, were considered. However, the mass was wall-adherent with imaging characteristics consistent with thrombus. The absence of echocardiographic signs of right heart strain made these alternative diagnoses unlikely. Moreover, the presence of PE would not have altered the therapeutic strategy. Detection of RV thrombus through multimodality imaging prompted initiation of anticoagulation, initially planned for three months. Follow-up imaging confirmed thrombus resolution, allowing treatment adjustment and underscoring the pivotal role of cardiac imaging in guiding management in the absence of robust evidence on optimal anticoagulation duration. This case highlights the value of advanced imaging in detecting atypical infarct patterns and rare complications with important implications for prognosis and management. Lead author biography Tamar Bigvava, MD, is a cardiologist from Tbilisi, Georgia, subspecialising in non-invasive cardiac imaging, including echocardiography, cardiac computed tomography, and cardiovascular magnetic resonance imaging. She is recipient of the 2025 ESC Training Grant in Cardiovascular Magnetic Resonance Imaging and completed the advanced CMR training at the University Hospital Zurich, Switzerland. She is currently working at the German Heart Centre of Charité in Berlin, Germany, in the department of Cardiovascular Magnetic Resonance Imaging. Supplementary Material Contributor Information Tamar Bigvava, Department of Cardiology, Angiology and Intensive Care Medicine, Deutsches Herzzentrum der Charité, Augustenburger Platz 1, 13353 Berlin, Germany; Department of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland. Andres Hoechli, Hirslanden Klinik Aarau, Kardiologie Mittelland, Schänisweg 1, CH 5001 Aarau, Switzerland. Pablo Anabitarte, Hirslanden Klinik Aarau, Kardiologie Mittelland, Schänisweg 1, CH 5001 Aarau, Switzerland. Robert Manka, Department of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Raemistrasse 101, CH 8092 Zurich, Switzerland. Verena C Wilzeck, Department of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Hirslanden Klinik Aarau, Kardiologie Mittelland, Schänisweg 1, CH 5001 Aarau, Switzerland; Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistrasse 100, Zurich 8091, Switzerland; Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Raemistrasse 101, CH 8092 Zurich, Switzerland. Supplementary material Supplementary material is available at European Heart Journal – Case Reports online. Consent: Written informed consent for publication of this case (including images) was obtained from the patient. Funding None. Data availability All relevant data supporting the findings of this study are included within the article and its supplementary materials. Additional data may be available from the corresponding author upon reasonable request, subject to patient privacy considerations. References Associated Data Supplementary Materials Data Availability Statement All relevant data supporting the findings of this study are included within the article and its supplementary materials. Additional data may be available from the corresponding author upon reasonable request, subject to patient privacy considerations.